Related Experiment Video
Updated: Feb 15, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology
Habib Zarredar1,2, Khalil Ansarin1, Behzad Baradaran3
1a Tuberculosis and Lung Disease Research Center , Tabriz University of Medical Science , Tabriz , Iran.
Abstract:
Lung cancer is the leading cause of cancer-related mortality with about 1.6 million deaths every year worldwide. Gene mutations and overexpression of oncogenes play a central role in malignant transformation in NSCLC. Conventional approaches for treatments of NSCLC have shown low levels of success while showing severe side effects. Target therapy using siRNA has recently emerged as a new strategy for cancer treatment by specific targeting of genes involved in the development and metastasis of cancer. This article dedicated to an update review of molecular targets could potentially be used for target therapy of lung cancer using SiRNA technology.
Insights
Lung cancer causes over 1.6 million deaths annually. This review explores novel small interfering RNA (siRNA) therapies targeting specific gene mutations for effective non-small cell lung cancer (NSCLC) treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer mortality globally.
- Non-small cell lung cancer (NSCLC) pathogenesis involves gene mutations and oncogene overexpression.
- Current NSCLC treatments have limited efficacy and significant side effects.
Purpose of the Study:
- To review emerging molecular targets for lung cancer treatment.
- To highlight the potential of small interfering RNA (siRNA) technology in targeted cancer therapy.
- To provide an update on siRNA-based therapeutic strategies for NSCLC.
Main Methods:
- Literature review of recent studies on lung cancer molecular targets.
- Analysis of gene mutations and oncogene overexpression in NSCLC.
- Evaluation of siRNA technology for targeted gene silencing.
Main Results:
- Identification of key molecular targets implicated in NSCLC development and metastasis.
- Demonstration of siRNA's specificity in targeting cancer-related genes.
- Overview of potential therapeutic applications of siRNA in NSCLC.
Conclusions:
- siRNA-based targeted therapy offers a promising new strategy for NSCLC treatment.
- Targeting specific genes with siRNA can overcome limitations of conventional therapies.
- Further research into molecular targets is crucial for advancing siRNA therapy for lung cancer.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Lung Capacity
Small interfering RNAs (siRNA)
Molecular Models

